CliffBio
small molecule

OMIDRIA

KETOROLAC TROMETHAMINE; PHENYLEPHRINE HYDROCHLORIDE

Loss of exclusivityApril 2034latest FDA-listed patent expiry
CompanyRAYNER SURGICAL INC

Drug detail

Brand nameOMIDRIA
Active ingredientKETOROLAC TROMETHAMINE; PHENYLEPHRINE HYDROCHLORIDE
StrengthEQ 0.3% BASE;EQ 1% BASE
Dosage formSOLUTION
RouteIRRIGATION
ModalitySmall molecule
FDA approvalMay 2014
Marketing statusRX

Listed patents

PatentExpiresType
9066856*PEDApril 2034—
9486406*PEDApril 2034—
9486406October 2033product
9066856October 2033product
9855246October 2033product

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

OMIDRIA patent cliff — loss of exclusivity April 2034 | CliffBio